BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

879 related articles for article (PubMed ID: 25862635)

  • 1. Templated misfolding of Tau by prion-like seeding along neuronal connections impairs neuronal network function and associated behavioral outcomes in Tau transgenic mice.
    Stancu IC; Vasconcelos B; Ris L; Wang P; Villers A; Peeraer E; Buist A; Terwel D; Baatsen P; Oyelami T; Pierrot N; Casteels C; Bormans G; Kienlen-Campard P; Octave JN; Moechars D; Dewachter I
    Acta Neuropathol; 2015 Jun; 129(6):875-94. PubMed ID: 25862635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterotypic seeding of Tau fibrillization by pre-aggregated Abeta provides potent seeds for prion-like seeding and propagation of Tau-pathology in vivo.
    Vasconcelos B; Stancu IC; Buist A; Bird M; Wang P; Vanoosthuyse A; Van Kolen K; Verheyen A; Kienlen-Campard P; Octave JN; Baatsen P; Moechars D; Dewachter I
    Acta Neuropathol; 2016 Apr; 131(4):549-69. PubMed ID: 26739002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tau pathology spread in PS19 tau transgenic mice following locus coeruleus (LC) injections of synthetic tau fibrils is determined by the LC's afferent and efferent connections.
    Iba M; McBride JD; Guo JL; Zhang B; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2015 Sep; 130(3):349-62. PubMed ID: 26150341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracerebral injection of preformed synthetic tau fibrils initiates widespread tauopathy and neuronal loss in the brains of tau transgenic mice.
    Peeraer E; Bottelbergs A; Van Kolen K; Stancu IC; Vasconcelos B; Mahieu M; Duytschaever H; Ver Donck L; Torremans A; Sluydts E; Van Acker N; Kemp JA; Mercken M; Brunden KR; Trojanowski JQ; Dewachter I; Lee VM; Moechars D
    Neurobiol Dis; 2015 Jan; 73():83-95. PubMed ID: 25220759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-dependent impairment of cognitive and synaptic function in the htau mouse model of tau pathology.
    Polydoro M; Acker CM; Duff K; Castillo PE; Davies P
    J Neurosci; 2009 Aug; 29(34):10741-9. PubMed ID: 19710325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propagation of tau pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.
    Lewis J; Dickson DW
    Acta Neuropathol; 2016 Jan; 131(1):27-48. PubMed ID: 26576562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The twenty-four KDa C-terminal tau fragment increases with aging in tauopathy mice: implications of prion-like properties.
    Matsumoto SE; Motoi Y; Ishiguro K; Tabira T; Kametani F; Hasegawa M; Hattori N
    Hum Mol Genet; 2015 Nov; 24(22):6403-16. PubMed ID: 26374846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer's disease and PART.
    Kaufman SK; Del Tredici K; Thomas TL; Braak H; Diamond MI
    Acta Neuropathol; 2018 Jul; 136(1):57-67. PubMed ID: 29752551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel human neuronal tau model exhibiting neurofibrillary tangles and transcellular propagation.
    Reilly P; Winston CN; Baron KR; Trejo M; Rockenstein EM; Akers JC; Kfoury N; Diamond M; Masliah E; Rissman RA; Yuan SH
    Neurobiol Dis; 2017 Oct; 106():222-234. PubMed ID: 28610892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A seeding based cellular assay of tauopathy.
    Xu Y; Martini-Stoica H; Zheng H
    Mol Neurodegener; 2016 Apr; 11():32. PubMed ID: 27112488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early-onset cognitive deficits and axonal transport dysfunction in P301S mutant tau transgenic mice.
    Onishi T; Matsumoto Y; Hattori M; Obayashi Y; Nakamura K; Yano T; Horiguchi T; Iwashita H
    Neurosci Res; 2014 Mar; 80():76-85. PubMed ID: 24406748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits.
    Schindowski K; Bretteville A; Leroy K; Bégard S; Brion JP; Hamdane M; Buée L
    Am J Pathol; 2006 Aug; 169(2):599-616. PubMed ID: 16877359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau Misfolding Efficiently Propagates between Individual Intact Hippocampal Neurons.
    Hallinan GI; Vargas-Caballero M; West J; Deinhardt K
    J Neurosci; 2019 Nov; 39(48):9623-9632. PubMed ID: 31658988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular Vesicles Containing P301L Mutant Tau Accelerate Pathological Tau Phosphorylation and Oligomer Formation but Do Not Seed Mature Neurofibrillary Tangles in ALZ17 Mice.
    Baker S; Polanco JC; Götz J
    J Alzheimers Dis; 2016 Oct; 54(3):1207-1217. PubMed ID: 27567840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the evidence that tau pathology spreads through prion-like propagation?
    Mudher A; Colin M; Dujardin S; Medina M; Dewachter I; Alavi Naini SM; Mandelkow EM; Mandelkow E; Buée L; Goedert M; Brion JP
    Acta Neuropathol Commun; 2017 Dec; 5(1):99. PubMed ID: 29258615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short Fibrils Constitute the Major Species of Seed-Competent Tau in the Brains of Mice Transgenic for Human P301S Tau.
    Jackson SJ; Kerridge C; Cooper J; Cavallini A; Falcon B; Cella CV; Landi A; Szekeres PG; Murray TK; Ahmed Z; Goedert M; Hutton M; O'Neill MJ; Bose S
    J Neurosci; 2016 Jan; 36(3):762-72. PubMed ID: 26791207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct differences in prion-like seeding and aggregation between Tau protein variants provide mechanistic insights into tauopathies.
    Strang KH; Croft CL; Sorrentino ZA; Chakrabarty P; Golde TE; Giasson BI
    J Biol Chem; 2018 Feb; 293(7):2408-2421. PubMed ID: 29259137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrastructural neuronal pathology in transgenic mice expressing mutant (P301L) human tau.
    Lin WL; Lewis J; Yen SH; Hutton M; Dickson DW
    J Neurocytol; 2003 Nov; 32(9):1091-105. PubMed ID: 15044841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered Intrinsic Pyramidal Neuron Properties and Pathway-Specific Synaptic Dysfunction Underlie Aberrant Hippocampal Network Function in a Mouse Model of Tauopathy.
    Booth CA; Witton J; Nowacki J; Tsaneva-Atanasova K; Jones MW; Randall AD; Brown JT
    J Neurosci; 2016 Jan; 36(2):350-63. PubMed ID: 26758828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.